Nestle SA is poised to exit the dermatology market after entering “exclusive negotiations” with a private-equity consortium led by EQT AB to divest its Skin Health operation for CHF10.2bn ($10.1bn).
The purchase price represents 3.6-times Skin Health's 2018 sales, which advanced at a “mid-single digit” rate to CHF2.8 billion, following what Nestlé CEO Mark Schneider hailed as a “stunning” turnaround
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?